Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis
Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis
The purpose of this study is to examine the long-term safety of treating recurrent episodes
 of tinea pedis for 14 days for each recurrence and recurrent episodes of tinea corporis or
 tinea cruris for 7 days for each recurrence with Product 33525.
Inclusion Criteria:

 -  Evidence of tinea cruris, tinea pedis, or tinea corporis. Additional criteria listed
 in protocol

 Exclusion Criteria:

 -  Pregnancy and allergies. Additional criteria listed in protocol